NCT04585204 Comparison of the Detection Rates of 50 Gr-100 Gr OGTT and 75 Gr OGTT That Require Medical Treatment of GDM
| NCT ID | NCT04585204 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara City Hospital Bilkent |
| Condition | Gestational Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,282 participants |
| Start Date | 2020-10-01 |
| Primary Completion | 2024-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,282 participants in total. It began in 2020-10-01 with a primary completion date of 2024-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Both 50 gr OGTT-100 gr OGTT and 75 gr OGTT are used for detecting gestational diabetes mellitus. Two approaches are approved by obstetricians. With this study, we aim to compare the gestational diabetes mellitus detection rate of these different tests.
Eligibility Criteria
Inclusion Criteria: * Pregnant women Exclusion Criteria: * Already diagnosed by diabetes mellitus * Multiple pregnancy
Frequently Asked Questions
Who can join the NCT04585204 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Gestational Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04585204 currently recruiting?
Yes, NCT04585204 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ankara City Hospital Bilkent to inquire about joining.
Where is the NCT04585204 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT04585204 clinical trial?
NCT04585204 is sponsored by Ankara City Hospital Bilkent. The trial plans to enroll 2,282 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.